Antidepressants in pregnancy won't harm baby's heart, study suggests

June 18, 2014 by Barbara Bronson Gray, Healthday Reporter
Antidepressants in pregnancy won't harm baby's heart, study suggests
But, past research shows risks, and one expert says this study doesn't provide definitive answers.

(HealthDay)—Antidepressants taken during the first three months of pregnancy don't appear to increase the risk of heart defects in babies, new research suggests.

However, this latest study contradicts previous research that found that taking in pregnancy can be risky.

The question is an important one because depression is common in pregnancy. It's diagnosed in 10 percent to 20 percent of pregnant women, and up to 13 percent of women take antidepressants while pregnant, according to the researchers.

"The most critical period in the development of an embryo or in the growth of a particular organ is during the time of most rapid cell division," said Krista Huybrechts, lead study author and epidemiologist at the Brigham and Women's Hospital, in Boston. So, it is in the first three months of pregnancy that the risk for developing major malformations is highest, she explained.

The U.S. government-funded research was published in the June 19 issue of the New England Journal of Medicine.

The current study's findings run counter to two previous studies that caused the U.S. Food and Drug Administration in 2005 to formally warn that early prenatal exposure to paroxetine (Paxil) may increase the risk of heart malformations at birth.

Huybrechts and her team had some concerns about the earlier research and wanted to re-examine the evidence by designing their study differently. They tightened the focus and took more factors that could interfere with the data into account, she said. The team looked at whether antidepressants, including those called selective serotonin reuptake inhibitors, or SSRIs—such as paroxetine (Paxil) and sertraline (Zoloft)—are indeed associated with an increased risk of heart defects at birth.

The researchers tapped data from 46 states and Washington, D.C., from 2000 through 2007. They were able to use demographic information, such as age, income and education, as well as data about all physician services and hospitalizations, including diagnoses, procedures and filled outpatient prescriptions.

A total of almost a million women who had given birth were included in the study. They were all on Medicaid without supplementary private insurance. All of the women were between 12 to 55 years of age. Women were excluded if they had been treated with drugs that have been associated with (such as chemotherapy, lithium, retinoids and thalidomide) or if their infants had been diagnosed with a genetic abnormality.

A total of about 64,000 (6.8 percent) of the women used antidepressants in the first three months of pregnancy. After adjusting the data to account for other factors that might increase the risk of a heart defect, the researchers found almost no difference in the risk of a baby being born with a heart defect between mothers who had been on antidepressants and those who hadn't.

But one expert does not find the results of the study reassuring. "While this is an excellent group of researchers, there are some serious flaws with this study," said Dr. Adam Urato, maternal-fetal medicine specialist at Tufts Medical Center, in Boston.

"This isn't rocket science. We know that exposing developing babies to synthetic chemicals is almost always a really bad idea and should be avoided whenever possible," said Urato. "This study does nothing to alter that common sense conclusion."

Urato said there were several specific problems with the study. Analysis of the huge database was likely to have misclassified whether women were indeed taking their antidepressants (not just picking up the prescription), which would make the medications look safer than they actually are, he explained.

The study didn't identify miscarriages, which are linked to antidepressants. "It may be that the most severely affected pregnancies are miscarrying," Urato said.

And he questioned why evidence of smoking and weight issues weren't considered in the data analysis. "We know that smoking is common in a Medicaid population and that it's associated with ," Urato said, "and body mass index [a measurement based on height and weight] may also influence this."

Urato added that because current research suggests that antidepressant use —especially SSRIs like Paxil and Zoloft—is associated with increased risk of miscarriage, birth defects, preterm birth, early rupture of membranes, preeclampsia (high blood pressure associated with pregnancy), and neurological problems in newborns, among other issues, should not take them.

As for a potential risk of suicide in a woman who is pregnant and seriously depressed, Urato said the evidence still suggests antidepressants are an unsafe option. "The evidence is that antidepressant use is associated with suicide in young people who take those medications," he said.

So, where does that leave a depressed woman who is pregnant?

"The best available current evidence strongly suggests that for most women, nondrug approaches to mental health issues such as psychotherapy and exercise provides as much—or more— benefit than chemical antidepressants," said Urato. These nondrug therapies should be tried first in who are pregnant or of childbearing age, he added.

Explore further: Antidepressants during pregnancy linked to preterm birth

More information: Learn more about pregnancy and depression from the U.S. Centers for Disease Control and Prevention.

Related Stories

Antidepressants during pregnancy linked to preterm birth

March 27, 2014
Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear ...

Proof that antidepressants and breastfeeding can mix

April 10, 2014
(Medical Xpress)—University of Adelaide researchers have found that women on antidepressant medication are more successful at breastfeeding their babies if they keep taking the medication, compared with women who quit antidepressants ...

Antidepressants for pregnant moms don't affect infants' growth, research says

March 20, 2013
Selective serotonin reuptake inhibitor (SSRI) antidepressants taken by a woman during pregnancy do not impact her infant's growth over the first year, reports a new study from a Northwestern Medicine scientist.

Antidepressants -- not depression -- increase risk of preterm birth, study shows

May 28, 2012
(Medical Xpress) -- Women who are depressed during pregnancy are not at higher risk of giving birth prematurely than non-depressed women — but those who take antidepressants during pregnancy seem to be, a new study ...

Smoking during pregnancy may raise risk for heart defects in babies

May 3, 2014
Women who smoke during pregnancy may be putting their newborns at risk for congenital heart defects, and the more they smoke, the higher the risk, according to a study to be presented Saturday, May 3, at the Pediatric Academic ...

PTSD, major depressive episode appears to increase risk of preterm birth

June 11, 2014
Diagnoses of both posttraumatic stress disorder (PTSD) and a major depressive episode appear to be associated with a sizable increase in risk for preterm birth that seems to be independent of antidepressant and benzodiazepine ...

Recommended for you

NeuroNext biomarker study explores natural history of infantile-onset SMA

January 9, 2018
Research led by The Ohio State University Wexner Medical Center to define the natural history of infantile-onset spinal muscular atrophy (SMA) has been "critical" to accelerate the development of effective therapies and hasten ...

No link between childhood lead levels, later criminality

December 27, 2017
(HealthDay)— Exposure to higher levels of lead during early childhood can affect neurological development—but does that mean affected kids are doomed to delinquency?

Early puberty in girls may take mental health toll

December 26, 2017
(HealthDay)—A girl who gets her first menstrual period early in life—possibly as young as 7—has a greater risk for developing depression and antisocial behaviors that last at least into her 20s, a new study suggests.

Technology not taking over children's lives despite screen-time increase

December 21, 2017
With children spending increasing amounts of time on screen-based devices, there is a common perception that technology is taking over their lives, to the detriment and exclusion of other activities. However, new Oxford University ...

Higher blood sugar in early pregnancy raises baby's heart-defect risk

December 15, 2017
Higher blood sugar early in pregnancy raises the baby's risk of a congenital heart defect, even among mothers who do not have diabetes, according to a study led by researchers at the Stanford University School of Medicine.

Injuries from window blinds send two children to the emergency department every day

December 11, 2017
Most homes have them. They help keep our rooms warm or cold and even add a pop of color to tie the décor together. But window blinds can cause serious injuries or even death to young children. A new study from the Center ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.